Berlin, Germany / France, 25 September 2026 – mediaire, a developer of AI solutions for magnetic resonance imaging (MRI), today announces a scientific partnership with Olympe Imagerie. The collaboration aims to drive continuous improvement in clinical workflows through mdprostate, mediaire’s AI solution for prostate MRI, while leveraging shared data and real-world clinical experience to expand the learning pool and generate scientific evidence on its benefits in clinical practice.
With six MRI scanners, 24/7 imaging activity and close collaborations with urology teams, Olympe Imagerie offers a particularly valuable clinical environment for this initiative. Its involvement in the diagnostic pathway and follow-up of patients undergoing prostate biopsies provides an opportunity to evaluate mdprostate in the context of real-world clinical workflows.
The partnership will be led by Dr. Schull, a radiologist specializing in prostate imaging and an active member of the French Society of Genitourinary Imaging (SIGU) and the European Society of Urogenital Radiology (ESUR). His expertise will help identify clinical needs, guide product development and support scientific studies designed to assess the benefits of mdprostate in routine practice.
Combining technological innovation with scientific curiosity
“With the arrival of two new MRI scanners, we knew that AI would become an ally in managing our increasing workload. But being able to combine this strategic decision with scientific curiosity is an excellent opportunity. While AI is still far from replacing an expert radiologist, it already provides practical support in our daily practice: offering a second reading, supporting less experienced radiologists and trainees, improving communication with referring urologists, and helping to target biopsies more precisely. We are eager to contribute to demonstrating these benefits through scientific research.”
– Dr. Schull, Radiologist specializing in prostate imaging, Olympe Imagerie
A partnership shaped by clinical practice
“Olympe Imagerie brings together two qualities we particularly value in a scientific partner: a commitment to making clinical workflows as efficient as possible, and genuine scientific curiosity, with a desire to contribute to product development. This collaboration comes at a strategic time for mediaire as we accelerate our expansion in France. We have already received particularly interesting clinical cases and challenged our upcoming developments against the needs of radiologists, helping us ensure that mdprostate continues to evolve in line with clinical practice in Southern Europe.”
– Cécile Hourquet, Scientific & Product Marketing Lead, mediaire
Developing mdprostate through clinical collaboration
Beyond evaluating the solution, the partnership is intended to foster an ongoing exchange between Olympe Imagerie’s clinical teams and mediaire’s product team. Clinical cases and feedback from daily practice will help identify concrete areas for improvement, while joint scientific studies will contribute to documenting the performance and clinical benefits of mdprostate.
This collaboration reflects mediaire’s commitment to developing AI solutions that are grounded in the needs of radiologists and designed to support their everyday practice.
